ELYS (ELYS)

Eli Lilly is currently trading at 34x forward earnings. That seems too high relative to the average of 18.8x for healthcare stocks, but for a company that has posted significantly higher revenue and earnings growth than similarly sized peers -- and is likely to continue doing so for the foreseeable …

Over the past year Eli Lilly (LLY) stock returned about 52%, moving from $757.59 to $1,154.97 while the S&P 500 returned 17.7%. A gap that size looks like something blindsided the market. Nothing did. The story it moved on was laid out in public, with dates attached, months before the price caught u…

Shares of data analytics and digital solutions company ExlService Holdings (NASDAQ:EXLS) jumped 17.9% in the afternoon session after the stock continued to gain momentum following strong quarter 2026 earnings results, which exceeded Wall Street’s expectations and prompted management to raise ...

Eli Lilly (LLY) has delivered a powerful return of +51% over the past year, with much of that coming in the last three months, which saw a +41% gain. That performance has left the stock trading at $ 1,220.66 (as of July 28, 2026), about 20% above its 200-day moving average. While investors are clear…

The stock was last up 1.09% at $26.06, compared with a previous close of $25.78, putting it near the middle of its 52-week range. No EPS or revenue actual was provided against the forecast, so a direct earnings surprise could not be measured. Elis said H1 2026 showed “resilient, diversified ...